Description
Prescribed for various respiratory diseases such as
- emphysema with bronchitis pneumoconiosis,
- chronic inflammatory pulmonary conditions
Prescribed for various respiratory diseases such as
Settings | AMBROSAN SYRUP AMBROXOL 100ML remove | AMINOPHYLINE TABLETS 100S remove | Acrason Cream 10mg remove | AMBROX SYRUP 100ml remove | Acetazolamide Tablets 250mg remove | AMBROX DROPS 15ML remove |
---|---|---|---|---|---|---|
Image | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
SKU | ||||||
Rating | ||||||
Price | Sh3,000.00 | Sh4,000.00 | Sh3,750.00 | Sh3,000.00 | Sh20,000.00 | Sh2,500.00 |
Stock | ||||||
Availability | ||||||
Add to cart | ||||||
Description | Aminophylline tablets are a type of medicine known as a bronchodilator, which is used to treat respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other conditions that affect the lungs and airways. | Ambroxol syrup is a medicine used to treat respiratory conditions that involve the production of excess mucus, such as bronchitis, chronic obstructive pulmonary disease (COPD), asthma, and other conditions that affect the lungs and airways. |
| Ambroxol drops are a medicine used to treat respiratory conditions that involve the production of excess mucus, such as bronchitis, chronic obstructive pulmonary disease (COPD), asthma, and other conditions that affect the lungs and airways. | ||
Content | Prescribed for various respiratory diseases such as
| The main uses of Aminophylline tablets include:
| Acrason Cream is used for corticosteroid-responsive dermatoses, candidiasis, tinea versicolor, folliculitis, furunculosis, paronychia and minor bacterial skin infections. | The main uses of Ambroxol syrup include:
| Acetazolamide 250mg Tablets contain the active substance Acetazolamide. This belongs to a group of medicines known as carbonic anhydrase inhibitors. | The main uses of Ambroxol drops include:
|
Weight | ||||||
Dimensions | N/A | N/A | N/A | N/A | N/A | N/A |
Additional information |
Reviews
There are no reviews yet.